Artículo especialMedidas de seguridad viral del plasma destinado a transfusión y su aplicación en España
Referencias bibliográficas (78)
- et al.
Hepatitis C en España [revisión]
Med Clin (Barc)
(2006) - et al.
Appraisal of the evidence for the clinical use of FFP and plasma fractions
Best Pract Res Clin Haematol
(2006) - et al.
Update on pathogen reduction technology for therapeutic plasma: an overview
Transfus Apher Sci
(2006) - et al.
Pathogen inactivation techniques
Best Practice & Research Clin Haematol
(2006) Virus inactivation in blood components by photoactive phenothiazine dyes [revision]
Transfus Med Rev
(2002)- et al.
Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s oesophagus
Lancet
(2003) - et al.
Plasma and plasma components in the management of disseminated intravascular coagulation
Best Practice & Research Clin Haematol
(2006) - et al.
Plasma and plasma products in the treatment of massive haemorrhage
Best Practice & Research Clin Haematol
(2006) - et al.
Photooxidation of fibrinogen in the presence of methylene blue and its effects on polymerization
Biochem Biophys Acta
(1978) - et al.
The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices
Transfus Apher Sci
(2005)
Fundamentals of the psoralene-based HelinxTM technology for inactivation of infectious pathogens and leukocytes in platelets and plasma
Semin Hematol
(2001)
Preclinical safety of a nucleid acid-targeted HelinxTM compound: a clinical perspective
Semin Hematol
(2001)
Transfusion of pooled buffy coat platelet components with photochemical pathogen inactivation treatment: the euroSPRITE trial
Blood
(2003)
Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease
Blood
(2006)
The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends
Transfus Apher Sci
(2006)
Current and emerging infectious risk of blood transfusions
JAMA
(2003)
Residual risk of transfusion-transmited vírica infections in Spain, 1997-2002, and impact of nucleic acid testing
Euro Surveill
(2005)
Long-term survival after blood transfusion: a population based study in the North of England
Transfusion
(2004)
A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols
Transfusion
(2000)
Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union
Transfusion
(2003)
Cost-effectiveness of transfusing virus-inactivated plasma instead of standard plasma
Transfusion
(1999)
Update of cost-effectiveness analysis for solvent-detergent-treated plasma [carta]
JAMA
(1999)
Solvent/detergent-treated plasma: composition, efficacy, and safety
Curr Opin Hematol
(2004)
Prospective study on efficacy and tolerability of solvent/detergent-treated plasma in intensive care unit patients
Infusionsther Transfusionsmed
(1993)
Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and aacquired coagulation disorders
Blood Coagul Fibrinolysis
(1993)
SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available
Vox Sang
(1998)
A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation
Transfusion
(1999)
Comparison of solvent/detergent-inactivated plasma and fresh frozenplasma under routine clinical conditions
Infusionsther Transfusionsmed
(2000)
Evaluation of solvent/detergent plasma in patients with prolonged prothrombin time
Vox Sang
(2000)
Effects of solvent/detergent-treated plasma and fresh frozen plasma on hemostasis and fibrinolysis in complex coagulopathy following open-heart surgery
Vox Sang
(2002)
Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP®)
Anesth Analg
(2002)
Universal fresh frozen plasma (Uniplas): a safe product in open-heart surgery
Intensive Care Med
(2003)
Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: doping, pharmacokinetics and clinical efficacy
Haematologica
(2006)
Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies
Transfus Med
(2006)
Cited by (3)
The cryoprecipitate: That old unknown
2015, Revista Espanola de Anestesiologia y ReanimacionBlood transfusion: Current debates
2011, Hematologie
Copyright © 2007 Elsevier España S.L. All rights reserved.